Dr. Robert Lynn Sorenson, MD

Dr. Sorenson practices at Sorenson & Sorenson MD Inc in Berkeley, California.

Dr. Sorenson's NPI, 1235220799, was assigned on September 27, 2006. Dr. Sorenson graduated from UC San Diego School of Medicine in 1980. Dr. Sorenson holds California license G045092.

Dr. Sorenson's primary practice is Sorenson & Sorenson MD Inc, at 3010 Colby St, Berkeley, CA 94705 in Alameda County. The practice phone is (510) 848-1413.

Dr. Sorenson's primary practice is Sorenson & Sorenson MD Inc in Berkeley, California. Dmand AI also links Dr. Sorenson to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sorenson practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sorenson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sorenson is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Sorenson is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Sorenson treats.

CMS data shows 2,514 Medicare services from Dr. Sorenson across 16 procedure codes in 2024, for 965 Medicare patients. Medicare paid $228,714 for them.

CMS counts 965 Medicare patients who saw Dr. Sorenson in 2024. The largest group is 75 to 84, with 482 patients. 72% of them have high cholesterol, and 62% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sorenson's median patient age at 76, with 52% women.

In 2024, Dr. Sorenson wrote 1,304 Medicare Part D claims for 430 patients. 48% of them were for generic drugs. CMS names the drug for 1,201 of them, across 16 drugs with 11 or more claims each, at $178,636 in total drug cost. In 2023, CMS named 1,145 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sorenson for performance year 2024, reported as part of a group. Dr. Sorenson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of cataract surgery by Dr. Sorenson, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 48 papers to Dr. Sorenson, published from 2004 to 2011. The most frequent topics are Islets of Langerhans, Insulin and Insulin Secretion. Dr. Sorenson has published most often in Endocrinology. Dr. Sorenson's most frequent co-authors are David M. Kendall, MD, David A. Rothenberger, MD and Andrew Lee Sorenson, MD.

Dmand AI links Dr. Sorenson to 7 clinical trials, 2 of them phase 2 studies. Conditions studied include Dry Eye Syndromes, Lacrimal Apparatus Diseases and Cataract. Research Insight LLC sponsors the most, 2.

CMS Open Payments shows 43 general payments to Dr. Sorenson from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Glaukos Corporation paid the most, $696.

Dmand AI lists 3 awards for Dr. Sorenson, most recently Oakland Magazine in 2006.

Dr. Sorenson graduated from UC San Diego School of Medicine in 1980. Dr. Sorenson is a member of AAO.

Dr. Sorenson is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.